Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.570
+0.050 (1.98%)
At close: Aug 7, 2026, 4:00 PM EDT
2.543
-0.027 (-1.05%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,894,632
Market Cap
20.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | -9 | -45.00% |
| Dec 31, 2023 | 20 | 5 | 33.33% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Dec 31, 2021 | 12 | 1 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| NextCure | 40 |
| Daré Bioscience | 24 |
| Jasper Therapeutics | 22 |
| Atossa Therapeutics | 16 |
| Werewolf Therapeutics | 14 |
| Cocrystal Pharma | 10 |
CLRB News
- 9 days ago - Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026 - GlobeNewsWire
- 24 days ago - Cellectar Biosciences publishes iopofosine I 131 dose-escalation study results - TheFly
- 24 days ago - Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers - GlobeNewsWire
- 27 days ago - Cellectar Biosciences initiated with a Buy at Brookline - TheFly
- 2 months ago - Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 2 months ago - Cellectar Biosciences Slides: Corporate presentation - Filings
- 2 months ago - Cellectar Biosciences Registration statement: Registration filing - Filings
- 2 months ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings